Dowload the free PDF file of Report Sample Pages. Cognitive Market Research has recently published report titled, "Meningococcal Conjugate Vaccine Market 2020" which provides detailed analysis of Meningococcal Conjugate Vaccine Market. The market study focuses on understanding industry dynamics along with driving factors to provide the key elements fueling the current market growth. The report also identifies restraints for Meningococcal Conjugate Vaccine market, to understand factors which will restrict the growth of Meningococcal Conjugate Vaccine market. Key industrial factors such as macroeconomic and microeconomic factors are studied in depth with the help of PESTEL analysis in order to have a holistic view of factors impacting Meningococcal Conjugate Vaccine market growth in various regions across the globe. Market forecast takes place with the help of complex algorithms such as regression analysis, sentiment analysis of end-users, etc.

1. 1
Global Meningococcal Conjugate Vaccine Market
2020
Global
Meningococca
l Conjugate
Vaccine
Market, 2020

2. 2
Global Meningococcal Conjugate Vaccine Market
2020

3. 3
Global Meningococcal Conjugate Vaccine Market
2020
Table of Content
Chapter 1 Meningococcal Conjugate Vaccine Market
Overview..............................................................................15
1.1 Product Overview and Scope of Meningococcal Conjugate Vaccine..............................15
1.2 Drivers, Restraints, and Opportunities for Global Meningococcal Conjugate
Vaccine Market: .........................................................................................................16
1.2.1 Drivers for Global Meningococcal Conjugate Vaccine Market:..............................16
1.2.2 Restraints for Global Meningococcal Conjugate Vaccine Market: .........................16
1.2.3 Opportunities for Global Meningococcal Conjugate Vaccine Market:...................16
1.3 Meningococcal Conjugate Vaccine Segment by Type ...................................................17
1.3.1 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (%) Comparison by Type (2014-2020) ..............................................17
1.3.2 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by
Type in 2018 ........................................................................................................18
1.3.3 Menactra .............................................................................................................19
1.3.4 MENVEO..............................................................................................................20
1.4 Meningococcal Conjugate Vaccine Segment by Application .........................................21
1.4.1 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (%) Comparison by Application (2014-2020)....................................21
1.4.2 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by
Application in 2018 ..............................................................................................22
1.4.3 Children...............................................................................................................23
1.4.4 Adults ..................................................................................................................24
1.5 Global Meningococcal Conjugate Vaccine Market by Regions (2014-2020)...................25
1.5.1 Global Meningococcal Conjugate Vaccine Market Size and Growth Rate
(%) Comparison by Regions (2014-2020) ..............................................................25
1.5.2 North America Meningococcal Conjugate Vaccine Status and Prospect
(2014-2027)..........................................................................................................27
1.5.3 Europe Meningococcal Conjugate Vaccine Status and Prospect (2014-
2027) ...................................................................................................................28

4. 4
Global Meningococcal Conjugate Vaccine Market
2020
1.5.4 Asia Pacific Meningococcal Conjugate Vaccine Status and Prospect (2014-
2027) ...................................................................................................................29
1.5.5 Latin America Meningococcal Conjugate Vaccine Status and Prospect
(2014-2027)..........................................................................................................30
1.5.6 Middle East and Africa Meningococcal Conjugate Vaccine Status and
Prospect (2014-2027)...........................................................................................31
1.6 Global Meningococcal Conjugate Vaccine Market Size (2014-2027)..............................32
1.6.1 Global Meningococcal Conjugate Vaccine Revenue Status and Outlook
(2014-2027)..........................................................................................................32
Chapter 2 Global Meningococcal Conjugate Vaccine Market
Competition by Manufacturers (Subject To Data
Availability) .........................................................................33
2.1 Global Meningococcal Conjugate Vaccine Revenue and Share by Manufacturers
(2014-2018)................................................................................................................33
Chapter 3 Executive Summary...........................................................36
3.1 Global Meningococcal Conjugate Vaccine Market, 2014 – 2027, (USD Million) .............36
3.2 Global Meningococcal Conjugate Vaccine Market: Snapshot .......................................37
Chapter 4 COVID – 19 Impact Analysis on Meningococcal
Conjugate Vaccine Market ................................................38
4.1 Meningococcal Conjugate Vaccine Market – COVID – 19 Impact Analysis.....................38
4.2 Global Meningococcal Conjugate Vaccine Market – PESTEL Analysis ............................39
4.3 Global Meningococcal Conjugate Vaccine Market – Porters Five Forces Analysis..........40
Chapter 5 Global Meningococcal Conjugate Vaccine Sales
by Regions (2014-2020).....................................................41
5.1 Global Meningococcal Conjugate Vaccine Revenue and Market Share (%) by
Regions (2014-2020)...................................................................................................41
Chapter 6 North America Meningococcal Conjugate Vaccine
Market Development Status and Outlook .......................44
6.1.1 North America Meningococcal Conjugate Vaccine Market by Country,
2014-2020............................................................................................................44
6.2 North America Meningococcal Conjugate Vaccine Market Size (2014-2020).................44
6.2.1 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2014-2020)......................................................................................46

5. 5
Global Meningococcal Conjugate Vaccine Market
2020
6.2.2 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Application (2014-2020) ...........................................................................47
Chapter 7 Europe Meningococcal Conjugate Vaccine Market
Development Status and Outlook....................................48
7.1.1 Europe Meningococcal Conjugate Vaccine Market by Country, 2014-2020...........48
7.2 Europe Meningococcal Conjugate Vaccine Market Size (2014-2020).............................48
7.2.1 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2014-2020) .................................................................................................50
7.2.2 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by
Application (2014-2020).......................................................................................51
Chapter 8 Asia Pacific Meningococcal Conjugate Vaccine
Market Development Status and Outlook .......................52
8.1.1 Asia Pacific Meningococcal Conjugate Vaccine Market by Country, 2014-
2020.....................................................................................................................52
8.2 Asia Pacific Meningococcal Conjugate Vaccine Market Size (2014-2020) ......................52
8.2.1 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size
by Type (2014-2020).............................................................................................54
8.2.2 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size
by Application (2014-2020) ..................................................................................55
Chapter 9 Latin America Meningococcal Conjugate Vaccine
Market Development Status and Outlook .......................56
9.1.1 Latin America Meningococcal Conjugate Vaccine Market by Country,
2014-2020............................................................................................................56
9.2 Latin America Meningococcal Conjugate Vaccine Market Size (2014-2020)...................56
9.2.1 Latin America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2014-2020)......................................................................................58
9.2.2 Latin America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Application (2014-2020) ...........................................................................59
Chapter 10 Middle East and Africa Meningococcal Conjugate
Vaccine Market Development Status and Outlook ........60
10.1.1 Middle East and Africa Meningococcal Conjugate Vaccine Market by
Country, 2014-2020..............................................................................................60
10.2 Middle East and Africa Meningococcal Conjugate Vaccine Market Size (2014-
2020) .........................................................................................................................60

6. 6
Global Meningococcal Conjugate Vaccine Market
2020
10.2.1 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD
Million) Size by Type (2014-2020).........................................................................62
10.2.2 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD
Million) Size by Application (2014-2020) ..............................................................63
Chapter 11 Global Meningococcal Conjugate Vaccine Market
Revenue (Value) by Type ..................................................64
11.1 Global Meningococcal Conjugate Vaccine Revenue and Market Share (%) by
Type (2014-2020) .......................................................................................................64
Chapter 12 Global Meningococcal Conjugate Vaccine Market
Revenue (Value) by Application.......................................67
12.1 Global Meningococcal Conjugate Vaccine Revenue and Market Share (%) by
Application (2014-2020) .............................................................................................67
Chapter 13 Global Meningococcal Conjugate Vaccine
Manufacturers Profiles/Analysis......................................70
13.1 GlaxoSmithKline.........................................................................................................70
13.1.1 GlaxoSmithKline Basic Information, Manufacturing Base, SalesArea and
its Competitors ....................................................................................................70
13.1.2 Meningococcal Conjugate Vaccine Types Specification.........................................71
13.1.3 Main Business/Business Overview.......................................................................72
13.2 Pfizer .........................................................................................................................72
13.3 Sanofi ........................................................................................................................72
Chapter 14 Meningococcal Conjugate Vaccine Manufacturing
Cost Analysis......................................................................73
14.1 Proportion of Manufacturing Cost Structure ...............................................................73
14.1.1 Raw Materials......................................................................................................73
14.1.2 Labor Cost............................................................................................................73
14.1.3 USA Labor CostAnalysis........................................................................................73
14.1.4 EU Labor Costs Analysis........................................................................................74
14.1.5 China Labor Costs Analysis...................................................................................74
14.1.6 Manufacturing Expenses......................................................................................74
Chapter 15 Market Effect Factors Analysis ........................................75
15.1 Consumer Needs/Customer Preference Change ..........................................................75

7. 7
Global Meningococcal Conjugate Vaccine Market
2020
15.2 Economic/Political Environmental Change ..................................................................75
Chapter 16 Global Meningococcal Conjugate Vaccine Market
Forecast (2020-2027) .........................................................77
16.1 Global Meningococcal Conjugate Vaccine Revenue Forecast (2020-2027).....................77
16.1.1 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (%) Forecast (2020-2027).................................................................77
16.2 Global Meningococcal Conjugate Vaccine Revenue (USD Million) Forecast by
Regions (2020-2027)...................................................................................................78
16.2.1 North America Meningococcal Conjugate Vaccine Revenue (USD Million)
Forecast (2020-2027)............................................................................................79
16.2.2 Europe Meningococcal Conjugate Vaccine Revenue (USD Million) Forecast
(2020-2027)..........................................................................................................79
16.2.3 Asia Pacific Meningococcal Conjugate Vaccine Revenue (USD Million)
Forecast (2020-2027)............................................................................................80
16.2.4 Latin America Meningococcal Conjugate Vaccine Revenue (USD Million)
Forecast (2020-2027)............................................................................................81
16.2.5 Middle East and Africa Meningococcal Conjugate Vaccine Revenue (USD
Million) Forecast (2020-2027)...............................................................................81
16.3 Global Meningococcal Conjugate Vaccine Revenue and Forecast by Type (2020-
2027) .........................................................................................................................83
16.4 Global Meningococcal Conjugate Vaccine Revenue and Forecast by Application
(2020-2027)................................................................................................................83
Chapter 17 North America Meningococcal Conjugate Vaccine
Market Forecast 2020-2027...............................................86
17.1 North America............................................................................................................86
17.1.1 North America Meningococcal Conjugate Vaccine Market by Country,
2020-2027............................................................................................................86
17.1.2 North America Meningococcal Conjugate Vaccine Market Size (2020-2027).........86
17.1.3 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)......................................................................................87
17.1.4 North America Meningococcal Conjugate Vaccine Revenue Market Size by
Type 2022 ............................................................................................................87
17.1.5 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Application (2020-2027) ...........................................................................88
17.1.6 North America Meningococcal Conjugate Vaccine Revenue Market Size by
Application 2022..................................................................................................88

8. 8
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 18 Europe Meningococcal Conjugate Vaccine Market
Forecast 2020-2027............................................................90
18.1 Europe.......................................................................................................................90
18.1.1 Europe Meningococcal Conjugate Vaccine Market by Country, 2020-2027...........90
18.1.2 Europe Meningococcal Conjugate Vaccine Market Size (2020-2027).....................90
18.1.3 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) .................................................................................................91
18.1.4 Europe Meningococcal Conjugate Vaccine Revenue Market Size by Type
2022.....................................................................................................................91
18.1.5 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by
Application (2020-2027).......................................................................................92
18.1.6 Europe Meningococcal Conjugate Vaccine Revenue Market Size by
Application 2022..................................................................................................92
Chapter 19 Asia Pacific Meningococcal Conjugate Vaccine
Market Forecast 2020-2027...............................................94
19.1 Asia Pacific.................................................................................................................94
19.1.1 Asia Pacific Meningococcal Conjugate Vaccine Market by Country, 2020-
2027.....................................................................................................................94
19.1.2 Asia Pacific Meningococcal Conjugate Vaccine Market Size (2020-2027) ..............94
19.1.3 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size
by Type (2020-2027).............................................................................................95
19.1.4 Asia Pacific Meningococcal Conjugate Vaccine Revenue Market Size by
Type 2022 ............................................................................................................95
19.1.5 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size
by Application (2020-2027) ..................................................................................96
19.1.6 Asia Pacific Meningococcal Conjugate Vaccine Revenue Market Size by
Application 2022..................................................................................................96
Chapter 20 Latin America Meningococcal Conjugate Vaccine
Market Forecast 2020-2027...............................................98
20.1 Latin America.............................................................................................................98
20.1.1 Latin America Meningococcal Conjugate Vaccine Market by Country,
2020-2027............................................................................................................98
20.1.2 Latin America Meningococcal Conjugate Vaccine Market Size (2020-2027) ..........98
20.1.3 Latin America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)......................................................................................99

9. 9
Global Meningococcal Conjugate Vaccine Market
2020
20.1.4 Latin America Meningococcal Conjugate Vaccine Revenue Market Size by
Type 2022 ............................................................................................................99
20.1.5 Latin America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Application (2020-2027) .........................................................................100
20.1.6 Latin America Meningococcal Conjugate Vaccine Revenue Market Size by
Application 2022................................................................................................100
Chapter 21 Middle East and Africa Meningococcal Conjugate
Vaccine Market Forecast 2020-2027 ............................. 102
21.1 Middle East and Africa..............................................................................................102
21.1.1 Middle East and Africa Meningococcal Conjugate Vaccine Market by
Country, 2020-2027............................................................................................102
21.1.2 Middle East and Africa Meningococcal Conjugate Vaccine Market Size
(2020-2027)........................................................................................................102
21.1.3 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD
Million) Size by Type (2020-2027).......................................................................103
21.1.4 Middle East and Africa Meningococcal Conjugate Vaccine Revenue Market
Size by Type 2022...............................................................................................103
21.1.5 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD
Million) Size by Application (2020-2027) ............................................................104
21.1.6 Middle East and Africa Meningococcal Conjugate Vaccine Revenue Market
Size by Application 2022 ....................................................................................104
Chapter 22 Research Findings and Conclusion ............................. 106

10. 10
Global Meningococcal Conjugate Vaccine Market
2020
List of Figures
FIG. 1 Product Picture of Meningococcal Conjugate Vaccine 15
FIG. 2 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by Type in
2018 18
FIG. 3 Global Menactra Market Revenue (USD Million) and Growth Rate (%), (2014 –
2027) 19
FIG. 4 Global MENVEO Market Revenue (USD Million) and Growth Rate (%), (2014 –
2027) 20
FIG. 5 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by
Application in 2018 22
FIG. 6 Global Children Market Revenue (USD Million) and Growth Rate (%), (2014 –
2027) 23
FIG. 7 Global Adults Market Revenue (USD Million) and Growth Rate (%), (2014 – 2027) 24
FIG. 8 Global Meningococcal Conjugate Vaccine Market Size Comparison and Growth
Rate (%) by Regions (2014-2020) 25
FIG. 9 North America Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (2014-2027) 27
FIG. 10 Europe Meningococcal Conjugate Vaccine Revenue (USD Million) and Growth
Rate (2014-2027) 28
FIG. 11 Asia Pacific Meningococcal Conjugate Vaccine Revenue (USD Million) and Growth
Rate (2014-2027) 29
FIG. 12 Latin America Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (2014-2027) 30
FIG. 13 Middle East and Africa Meningococcal Conjugate Vaccine Revenue (USD Million)
and Growth Rate (2014-2027) 31
FIG. 14 Global Meningococcal Conjugate Vaccine Revenue (USD Million) Status and
Outlook (2014-2027) 32
FIG. 15 2018 Global Meningococcal Conjugate Vaccine Revenue Share by Manufacturers 35
FIG. 16 Global Meningococcal Conjugate Vaccine Market, 2014 – 2027, (USD Million) 36
FIG. 17 Global Meningococcal Conjugate Vaccine Market – PESTEL Analysis 39
FIG. 18 Porter’s five forces analysis 40
FIG. 19 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by Regions
(2014-2020) 42
FIG. 20 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by Regions,
2018 43
FIG. 21 North America Meningococcal Conjugate Vaccine Market Share (%) by Country
(2014-2020) 44
FIG. 22 North America Meningococcal Conjugate Vaccine Market Size by Type 2017 46
FIG. 23 North America Meningococcal Conjugate Vaccine Market Size by Application 2017 47
FIG. 24 Europe Meningococcal Conjugate Vaccine Market Share (%) by Country (2014-
2020) 48
FIG. 25 Europe Meningococcal Conjugate Vaccine Market Size by Type 2017 50
FIG. 26 Europe Meningococcal Conjugate Vaccine Market Size by Application 2017 51

11. 11
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 27 Asia Pacific Meningococcal Conjugate Vaccine Market Share (%) by Country
(2014-2020) 52
FIG. 28 Asia Pacific Meningococcal Conjugate Vaccine Market Size by Type 2017 54
FIG. 29 Asia Pacific Meningococcal Conjugate Vaccine Market Size by Application 2017 55
FIG. 30 Latin America Meningococcal Conjugate Vaccine Market Share (%) by Country
(2014-2020) 56
FIG. 31 Latin America Meningococcal Conjugate Vaccine Market Size by Type 2017 58
FIG. 32 Latin America Meningococcal Conjugate Vaccine Market Size by Application 2017 59
FIG. 33 Middle East and Africa Meningococcal Conjugate Vaccine Market Share (%) by
Country (2014-2020) 60
FIG. 34 Middle East and Africa Meningococcal Conjugate Vaccine Market Size by Type
2017 62
FIG. 35 Middle East and Africa Meningococcal Conjugate Vaccine Market Size by
Application 2017 63
FIG. 36 Global Meningococcal Conjugate Vaccine Market Revenue Share (%) by Type
(2014-2020) 65
FIG. 37 2018 Revenue Market Share (%) of Meningococcal Conjugate Vaccine by Type 66
FIG. 38 Global Meningococcal Conjugate Vaccine Market Revenue Share (%) by
Application (2014-2020) 68
FIG. 39 2018 Revenue Market Share (%) of Meningococcal Conjugate Vaccine by
Application 69
FIG. 40 GlaxoSmithKline Revenue Market Share (%) (2014-2018) 72
FIG. 41 Manufacturing Cost Structure of Meningococcal Conjugate Vaccine 73
FIG. 42 Economic/Political Environmental Change 75
FIG. 43 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and Growth
Rate (%) Forecast (2020-2027) 77
FIG. 44 Global Meningococcal Conjugate Vaccine Revenue (USD Million) Market Share
(%) Forecast by Regions (2020-2027) 78
FIG. 45 North America Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (%) Forecast (2020-2027) 79
FIG. 46 Europe Meningococcal Conjugate Vaccine Revenue (USD Million) and Growth
Rate (%) Forecast (2020-2027) 79
FIG. 47 Asia Pacific Meningococcal Conjugate Vaccine Revenue (USD Million) and Growth
Rate (%) Forecast (2020-2027) 80
FIG. 48 Latin America Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (%) Forecast (2020-2027) 81
FIG. 49 Middle East and Africa Meningococcal Conjugate Vaccine Revenue (USD Million)
and Growth Rate (%) Forecast (2020-2027) 81
FIG. 50 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) Forecast by
Type (2020-2027) 83
FIG. 51 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) Forecast by
Application (2020-2027) 84
FIG. 52 North America Meningococcal Conjugate Vaccine Market Share (%) by Country
(2020-2027) 86

12. 12
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 53 North America Meningococcal Conjugate Vaccine Revenue Market Size by Type
2022 87
FIG. 54 North America Meningococcal Conjugate Vaccine Revenue Market Size by
Application 2022 88
FIG. 55 Europe Meningococcal Conjugate Vaccine Market Share (%) by Country (2020-
2027) 90
FIG. 56 Europe Meningococcal Conjugate Vaccine Revenue Market Size by Type 2022 91
FIG. 57 Europe Meningococcal Conjugate Vaccine Revenue Market Size by Application
2022 92
FIG. 58 Asia Pacific Meningococcal Conjugate Vaccine Market Share (%) by Country
(2020-2027) 94
FIG. 59 Asia Pacific Meningococcal Conjugate Vaccine Revenue Market Size by Type
2022 95
FIG. 60 Asia Pacific Meningococcal Conjugate Vaccine Revenue Market Size by
Application 2022 96
FIG. 61 Latin America Meningococcal Conjugate Vaccine Market Share (%) by Country
(2020-2027) 98
FIG. 62 Latin America Meningococcal Conjugate Vaccine Revenue Market Size by Type
2022 99
FIG. 63 Latin America Meningococcal Conjugate Vaccine Revenue Market Size by
Application 2022 100
FIG. 64 Middle East and Africa Meningococcal Conjugate Vaccine Market Share (%) by
Country (2020-2027) 102
FIG. 65 Middle East and Africa Meningococcal Conjugate Vaccine Revenue Market Size
by Type 2022 103
FIG. 66 Middle East and Africa Meningococcal Conjugate Vaccine Revenue Market Size
by Application 2022 104
List of Tables
TABLE 1 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and Growth
Rate (%) Comparison by Type (2014-2019) 17
TABLE 2 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and Growth
Rate (%) Comparison by Application (2014-2019) 21
TABLE 3 Meningococcal Conjugate Vaccine Market Revenue (USD Million) Comparison by
Regions (2014-2027) 26
TABLE 4 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by
Manufacturers (2014-2018) 33
TABLE 5 Global Meningococcal Conjugate Vaccine Revenue Share by Manufacturers
(2014-2018) 34
TABLE 6 Market Snapshot 37
TABLE 7 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by Regions
(2014-2020) 41
TABLE 8 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by Regions
(2014-2020) 41

13. 13
Global Meningococcal Conjugate Vaccine Market
2020
TABLE 9 North America Meningococcal Conjugate Vaccine Market by Country Revenue,
2014-2020 44
TABLE 10 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2014-2020) 46
TABLE 11 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Application (2014-2020) 47
TABLE 12 Europe Meningococcal Conjugate Vaccine Market by Country Revenue, 2014-
2020 48
TABLE 13 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by Type
(2014-2020) 50
TABLE 14 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by
Application (2014-2020) 51
TABLE 15 Asia Pacific Meningococcal Conjugate Vaccine Market by Country Revenue, 2014-
2020 52
TABLE 16 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size by Type
(2014-2020) 54
TABLE 17 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size by
Application (2014-2020) 55
TABLE 18 Latin America Meningococcal Conjugate Vaccine Market by Country Revenue,
2014-2020 56
TABLE 19 Latin America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2014-2020) 58
TABLE 20 Latin America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Application (2014-2020) 59
TABLE 21 Middle East and Africa Meningococcal Conjugate Vaccine Market by Country
Revenue, 2014-2020 60
TABLE 22 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2014-2020) 62
TABLE 23 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD Million)
Size by Application (2014-2020) 63
TABLE 24 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by Type (2014-
2020) 64
TABLE 25 Global Meningococcal Conjugate Vaccine Revenue Share (%) by Type (2014-
2020) 64
TABLE 26 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by Application
(2014-2020) 67
TABLE 27 Global Meningococcal Conjugate Vaccine Revenue Share (%) by Type (2014-
2020) 67
TABLE 28 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its
Competitors 70
TABLE 29 GlaxoSmithKline Revenue (USD Million), Gross Margin (%) and Market Share (%)
(2014-2018) 71
TABLE 30 Global Meningococcal Conjugate Vaccine Revenue (USD Million) Forecast by
Regions (2020-2027) 78
TABLE 31 Global Meningococcal Conjugate Vaccine Revenue (USD Million) Forecast by
Type (2020-2027) 83

14. 14
Global Meningococcal Conjugate Vaccine Market
2020
TABLE 32 Global Meningococcal Conjugate Vaccine Revenue (USD Million) Forecast by
Application (2020-2027) 83
TABLE 33 North America Meningococcal Conjugate Vaccine Market by Country Revenue,
2020-2027 86
TABLE 34 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 87
TABLE 35 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 88
TABLE 36 Europe Meningococcal Conjugate Vaccine Market by Country Revenue, 2020-
2027 90
TABLE 37 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 91
TABLE 38 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 92
TABLE 39 Asia Pacific Meningococcal Conjugate Vaccine Market by Country Revenue, 2020-
2027 94
TABLE 40 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 95
TABLE 41 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 96
TABLE 42 Latin America Meningococcal Conjugate Vaccine Market by Country Revenue,
2020-2027 98
TABLE 43 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 99
TABLE 44 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 100
TABLE 45 Middle East and Africa Meningococcal Conjugate Vaccine Market by Country
Revenue, 2020-2027 102
TABLE 46 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 103
TABLE 47 North America Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2020-2027) 104

15. 15
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 1 Meningococcal Conjugate Vaccine Market
Overview
1.1 Product Overview and Scope of Meningococcal Conjugate
Vaccine
FIG. 1 Product Picture of Meningococcal Conjugate Vaccine

16. 16
Global Meningococcal Conjugate Vaccine Market
2020
1.2 Drivers, Restraints, and Opportunities for Global
Meningococcal Conjugate Vaccine Market:
1.2.1 Drivers for Global Meningococcal Conjugate Vaccine
Market:
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
1.2.2 Restraints for Global Meningococcal Conjugate Vaccine
Market:
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
1.2.3 Opportunities for Global Meningococcal Conjugate
Vaccine Market:
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

17. 17
Global Meningococcal Conjugate Vaccine Market
2020
1.3 Meningococcal Conjugate Vaccine Segment by Type
1.3.1 Global Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (%) Comparison by Type
(2014-2020)
TABLE 1 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (%) Comparison by Type (2014-2019)
Market Segment Type 2014 2015 2016 2017 2018 2019
Menactra xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
MENVEO xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Total xx xx xx xx xx xx
-YOY (%) xx xx xx xx xx xx

18. 18
Global Meningococcal Conjugate Vaccine Market
2020
1.3.2 Global Meningococcal Conjugate Vaccine Revenue
Market Share (%) by Type in 2018
FIG. 2 Global Meningococcal Conjugate Vaccine Revenue Market
Share (%) by Type in 2018
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis

19. 19
Global Meningococcal Conjugate Vaccine Market
2020
1.3.3 Menactra
In 2014, the Menactra Revenue (USD Million) was USD xx Million and it expected to
reach at USD xx Million in 2027
FIG. 3 Global Menactra Market Revenue (USD Million) and Growth
Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

20. 20
Global Meningococcal Conjugate Vaccine Market
2020
1.3.4 MENVEO
In 2014, the MENVEO Revenue (USD Million) was USD xx Million and it expected to
reach at USD xx Million in 2027
FIG. 4 Global MENVEO Market Revenue (USD Million) and Growth
Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

21. 21
Global Meningococcal Conjugate Vaccine Market
2020
1.4 Meningococcal Conjugate Vaccine Segment by Application
1.4.1 Global Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (%) Comparison by
Application (2014-2020)
TABLE 2 Global Meningococcal Conjugate Vaccine Revenue (USD Million) and
Growth Rate (%) Comparison by Application (2014-2019)
Market Segment Type 2014 2015 2016 2017 2018 2019
Children xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Adults xx xx xx xx xx xx
-YOY (%) xx Xx xx xx xx Xx
Total xx xx xx xx xx xx
-YOY (%) xx xx xx xx xx xx

22. 22
Global Meningococcal Conjugate Vaccine Market
2020
1.4.2 Global Meningococcal Conjugate Vaccine Revenue
Market Share (%) by Application in 2018
FIG. 5 Global Meningococcal Conjugate Vaccine Revenue Market
Share (%) by Application in 2018
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis

23. 23
Global Meningococcal Conjugate Vaccine Market
2020
1.4.3 Children
In 2014, the Children Revenue (USD Million) was USD xx Million and it expected to
reach at USD xx Million in 2027
FIG. 6 Global Children Market Revenue (USD Million) and Growth
Rate (%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

24. 24
Global Meningococcal Conjugate Vaccine Market
2020
1.4.4 Adults
In 2014, the Adults Revenue (USD Million) was USD xx Million and it expected to
reach at USD xx Million in 2027
FIG. 7 Global Adults Market Revenue (USD Million) and Growth Rate
(%), (2014 – 2027)
Source: Secondary Research, Interviews, and Expert Analysis Secondary Research, Interviews, and Expert Analysis
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

25. 25
Global Meningococcal Conjugate Vaccine Market
2020
1.5 Global Meningococcal Conjugate Vaccine Market by Regions
(2014-2020)
1.5.1 Global Meningococcal Conjugate Vaccine Market Size
and Growth Rate (%) Comparison by Regions (2014-
2020)
FIG. 8 Global Meningococcal Conjugate Vaccine Market Size
Comparison and Growth Rate (%) by Regions (2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

26. 26
Global Meningococcal Conjugate Vaccine Market
2020
TABLE 3 Meningococcal Conjugate Vaccine Market Revenue (USD Million)
Comparison by Regions (2014-2027)
Region 2014 2019 2027 Market
Share
(%)
2027
CAGR (%)
(2019-2027)
North America xx xx xx xx Xx
Europe xx xx xx xx Xx
Asia Pacific xx xx xx xx Xx
Latin America xx xx xx xx Xx
Middle East and Africa xx xx xx xx Xx
Total xx xx xx xx xx

27. 27
Global Meningococcal Conjugate Vaccine Market
2020
1.5.2 North America Meningococcal Conjugate Vaccine
Status and Prospect (2014-2027)
The North America Meningococcal Conjugate Vaccine market size was USD xx
Million in 2014 and it will be USD xx Million in 2027.
FIG. 9 North America Meningococcal Conjugate Vaccine Revenue
(USD Million) and Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

28. 28
Global Meningococcal Conjugate Vaccine Market
2020
1.5.3 Europe Meningococcal Conjugate Vaccine Status and
Prospect (2014-2027)
The North America Meningococcal Conjugate Vaccine market size was USD xx
Million in 2014 and it will be USD xx Million in 2027.
FIG. 10 Europe Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

29. 29
Global Meningococcal Conjugate Vaccine Market
2020
1.5.4 Asia Pacific Meningococcal Conjugate Vaccine Status
and Prospect (2014-2027)
The North America Meningococcal Conjugate Vaccine market size was USD xx
Million in 2014 and it will be USD xx Million in 2027.
FIG. 11 Asia Pacific Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

30. 30
Global Meningococcal Conjugate Vaccine Market
2020
1.5.5 Latin America Meningococcal Conjugate Vaccine Status
and Prospect (2014-2027)
The North America Meningococcal Conjugate Vaccine market size was USD xx
Million in 2014 and it will be USD xx Million in 2027.
FIG. 12 Latin America Meningococcal Conjugate Vaccine Revenue
(USD Million) and Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

31. 31
Global Meningococcal Conjugate Vaccine Market
2020
1.5.6 Middle East and Africa Meningococcal Conjugate
Vaccine Status and Prospect (2014-2027)
The North America Meningococcal Conjugate Vaccine market size was USD xx
Million in 2014 and it will be USD xx Million in 2027.
FIG. 13 Middle East and Africa Meningococcal Conjugate Vaccine
Revenue (USD Million) and Growth Rate (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

32. 32
Global Meningococcal Conjugate Vaccine Market
2020
1.6 Global Meningococcal Conjugate Vaccine Market Size (2014-
2027)
1.6.1 Global Meningococcal Conjugate Vaccine Revenue
Status and Outlook (2014-2027)
The global Meningococcal Conjugate Vaccine Market is valued at USD xx Million in
2014 and is expected to reach USD xx Million by the end of 2027.
FIG. 14 Global Meningococcal Conjugate Vaccine Revenue (USD
Million) Status and Outlook (2014-2027)
Source: Secondary Research, Interviews, and Expert Analysis

33. 33
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 2 Global Meningococcal Conjugate Vaccine Market
Competition by Manufacturers (Subject To Data
Availability)
2.1 Global Meningococcal Conjugate Vaccine Revenue and Share
by Manufacturers (2014-2018)
TABLE 4 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by
Manufacturers (2014-2018)
Manufacturers 2014 2015 2016 2017 2018
GlaxoSmithKline xx xx xx xx Xx
Pfizer xx xx xx xx Xx
Sanofi xx xx xx xx Xx

34. 34
Global Meningococcal Conjugate Vaccine Market
2020
TABLE 5 Global Meningococcal Conjugate Vaccine Revenue Share by
Manufacturers (2014-2018)
Manufacturers 2014 2015 2016 2017 2018
GlaxoSmithKline xx xx xx xx Xx
Pfizer xx xx xx xx Xx
Sanofi xx xx xx xx Xx

35. 35
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 15 2018 Global Meningococcal Conjugate Vaccine Revenue Share
by Manufacturers
Source: Secondary Research, Interviews, and Expert Analysis

36. 36
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 3 Executive Summary
The global Meningococcal Conjugate Vaccine Market is valued at USD xx Million in
2014 and is expected to reach USD xx Million by the end of 2027, growing at a
CAGR of xx% between 2019 and 2027.
3.1 Global Meningococcal Conjugate Vaccine Market, 2014 –
2027, (USD Million)
FIG. 16 Global Meningococcal Conjugate Vaccine Market, 2014 – 2027,
(USD Million)
Source: Secondary Research, Interviews, and Expert Analysis
XX
XX
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 GrowthRate%
Revenue(USDMillion)
Revenue Growth Rate

37. 37
Global Meningococcal Conjugate Vaccine Market
2020
3.2 Global Meningococcal Conjugate Vaccine Market: Snapshot
TABLE 6 Market Snapshot
Meningococcal
Conjugate
Vaccine
Market
2014 2020
Global
Revenue
(USD Million)
xx xx
CAGR (2019 –
2025)
xx%
Key Type
Segment
(Revenue
Share)
Menactra:xx%
MENVEO:xx%
Menactra:xx%
MENVEO:xx%
Key
Application
Segment
(Revenue
Share)
Children:xx%
Adults:xx%
Children:xx%
Adults:xx%
Key Regional
Segment
(Revenue
Share)
North America: xx%
Europe: xx%
Asia Pacific: xx%
Latin America: xx%
Middle East and Africa: xx%
North America: xx%
Europe: xx%
Asia Pacific: xx%
Latin America: xx%
Middle East and Africa: xx%
Driver xxxxxxxxxxxxxxxx
Restraint xxxxxxxxxxxxxxxx
Opportunity xxxxxxxxxxxxxxxx

38. 38
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 4 COVID – 19 Impact Analysis on Meningococcal
Conjugate Vaccine Market
4.1 Meningococcal Conjugate Vaccine Market – COVID – 19
Impact Analysis
An analysis of the market developments between December 2019 to till date
revealed that product commercialization, developmental collaborations, and product
distribution partnerships were adopted by market players to maintain a competitive
position in the Meningococcal Conjugate Vaccine market to mitigate the COVID-19
impact. Product commercialization was the most widely adopted growth strategy.
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

39. 39
Global Meningococcal Conjugate Vaccine Market
2020
4.2 Global Meningococcal Conjugate Vaccine Market – PESTEL
Analysis
FIG. 17 Global Meningococcal Conjugate Vaccine Market – PESTEL
Analysis
Source: Secondary Research, Interviews, and Expert Analysis
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
PESTLE
Economic
Social
Legal
Enviornmental
Technological
Political

40. 40
Global Meningococcal Conjugate Vaccine Market
2020
4.3 Global Meningococcal Conjugate Vaccine Market – Porters
Five Forces Analysis
FIG. 18 Porter’s five forces analysis
Source: Secondary Research, Interviews, and Expert Analysis

41. 41
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 5 Global Meningococcal Conjugate Vaccine Sales by
Regions (2014-2020)
5.1 Global Meningococcal Conjugate Vaccine Revenue and
Market Share (%) by Regions (2014-2020)
TABLE 7 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by
Regions (2014-2020)
2014 2015 2016 2017 2018 2019 2020
North America xx xx xx xx xx xx Xx
Europe xx xx xx xx xx xx Xx
Asia Pacific xx xx xx xx xx xx Xx
Latin America xx xx xx xx xx xx Xx
Middle East and Africa xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
TABLE 8 Global Meningococcal Conjugate Vaccine Revenue Market Share (%) by
Regions (2014-2020)
2014 2015 2016 2017 2018 2019 2020
North America xx xx xx xx xx xx Xx
Europe xx xx xx xx xx xx Xx
Asia Pacific xx xx xx xx xx xx Xx
Latin America xx xx xx xx xx xx Xx
Middle East and Africa xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx

42. 42
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 19 Global Meningococcal Conjugate Vaccine Revenue Market
Share (%) by Regions (2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

43. 43
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 20 Global Meningococcal Conjugate Vaccine Revenue Market
Share (%) by Regions, 2018
Source: Secondary Research, Interviews, and Expert Analysis

44. 44
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 6 North America Meningococcal Conjugate Vaccine
Market Development Status and Outlook
6.1.1 North America Meningococcal Conjugate Vaccine
Market by Country, 2014-2020
TABLE 9 North America Meningococcal Conjugate Vaccine Market by Country
Revenue, 2014-2020
2014 2015 2016 2017 2018 2019 2020
U.S. xx xx xx xx xx xx Xx
Canada xx xx xx xx xx xx Xx
Mexico xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
6.2 North America Meningococcal Conjugate Vaccine Market
Size (2014-2020)
FIG. 21 North America Meningococcal Conjugate Vaccine Market Share
(%) by Country (2014-2020)

45. 45
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

46. 46
Global Meningococcal Conjugate Vaccine Market
2020
6.2.1 North America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Type (2014-2020)
TABLE 10 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Menactra xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 22 North America Meningococcal Conjugate Vaccine Market Size
by Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

47. 47
Global Meningococcal Conjugate Vaccine Market
2020
6.2.2 North America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Application (2014-2020)
TABLE 11 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Children xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 23 North America Meningococcal Conjugate Vaccine Market Size
by Application 2017
Source: Secondary Research, Interviews, and Expert Analysis

48. 48
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 7 Europe Meningococcal Conjugate Vaccine Market
Development Status and Outlook
7.1.1 Europe Meningococcal Conjugate Vaccine Market by
Country, 2014-2020
TABLE 12 Europe Meningococcal Conjugate Vaccine Market by Country Revenue,
2014-2020
2014 2015 2016 2017 2018 2019 2020
UK xx xx xx xx xx xx Xx
France xx xx xx xx xx xx Xx
Germany xx xx xx xx xx xx Xx
Italy xx xx xx xx xx xx Xx
Russia xx xx xx xx xx xx Xx
Spain xx xx xx xx xx xx Xx
Rest of Europe xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
7.2 Europe Meningococcal Conjugate Vaccine Market Size
(2014-2020)
FIG. 24 Europe Meningococcal Conjugate Vaccine Market Share (%)
by Country (2014-2020)

49. 49
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

50. 50
Global Meningococcal Conjugate Vaccine Market
2020
7.2.1 Europe Meningococcal Conjugate Vaccine Market (USD
Million) Size by Type (2014-2020)
TABLE 13 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by
Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Menactra xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 25 Europe Meningococcal Conjugate Vaccine Market Size by Type
2017
Source: Secondary Research, Interviews, and Expert Analysis

51. 51
Global Meningococcal Conjugate Vaccine Market
2020
7.2.2 Europe Meningococcal Conjugate Vaccine Market (USD
Million) Size by Application (2014-2020)
TABLE 14 Europe Meningococcal Conjugate Vaccine Market (USD Million) Size by
Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Children xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 26 Europe Meningococcal Conjugate Vaccine Market Size by
Application 2017
Source: Secondary Research, Interviews, and Expert Analysis

52. 52
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 8 Asia Pacific Meningococcal Conjugate Vaccine
Market Development Status and Outlook
8.1.1 Asia Pacific Meningococcal Conjugate Vaccine Market
by Country, 2014-2020
TABLE 15 Asia Pacific Meningococcal Conjugate Vaccine Market by Country
Revenue, 2014-2020
2014 2015 2016 2017 2018 2019 2020
China xx xx xx xx xx xx Xx
Japan xx xx xx xx xx xx Xx
India xx xx xx xx xx xx Xx
Korea xx xx xx xx xx xx Xx
South East Asia xx xx xx xx xx xx Xx
Rest of APAC xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
8.2 Asia Pacific Meningococcal Conjugate Vaccine Market Size
(2014-2020)
FIG. 27 Asia Pacific Meningococcal Conjugate Vaccine Market Share
(%) by Country (2014-2020)

53. 53
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

54. 54
Global Meningococcal Conjugate Vaccine Market
2020
8.2.1 Asia Pacific Meningococcal Conjugate Vaccine Market
(USD Million) Size by Type (2014-2020)
TABLE 16 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size
by Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Menactra xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 28 Asia Pacific Meningococcal Conjugate Vaccine Market Size by
Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

55. 55
Global Meningococcal Conjugate Vaccine Market
2020
8.2.2 Asia Pacific Meningococcal Conjugate Vaccine Market
(USD Million) Size by Application (2014-2020)
TABLE 17 Asia Pacific Meningococcal Conjugate Vaccine Market (USD Million) Size
by Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Children xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 29 Asia Pacific Meningococcal Conjugate Vaccine Market Size by
Application 2017
Source: Secondary Research, Interviews, and Expert Analysis

56. 56
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 9 Latin America Meningococcal Conjugate Vaccine
Market Development Status and Outlook
9.1.1 Latin America Meningococcal Conjugate Vaccine
Market by Country, 2014-2020
TABLE 18 Latin America Meningococcal Conjugate Vaccine Market by Country
Revenue, 2014-2020
2014 2015 2016 2017 2018 2019 2020
Brazil xx xx xx xx xx xx Xx
Argentina xx xx xx xx xx xx Xx
Columbia xx xx xx xx xx xx Xx
Rest of Latin America xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
9.2 Latin America Meningococcal Conjugate Vaccine Market Size
(2014-2020)
FIG. 30 Latin America Meningococcal Conjugate Vaccine Market Share
(%) by Country (2014-2020)

57. 57
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

58. 58
Global Meningococcal Conjugate Vaccine Market
2020
9.2.1 Latin America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Type (2014-2020)
TABLE 19 Latin America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Menactra xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 31 Latin America Meningococcal Conjugate Vaccine Market Size
by Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

59. 59
Global Meningococcal Conjugate Vaccine Market
2020
9.2.2 Latin America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Application (2014-2020)
TABLE 20 Latin America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Children xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 32 Latin America Meningococcal Conjugate Vaccine Market Size
by Application 2017
Source: Secondary Research, Interviews, and Expert Analysis

60. 60
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 10 Middle East and Africa Meningococcal Conjugate
Vaccine Market Development Status and Outlook
10.1.1 Middle East and Africa Meningococcal Conjugate
Vaccine Market by Country, 2014-2020
TABLE 21 Middle East and Africa Meningococcal Conjugate Vaccine Market by
Country Revenue, 2014-2020
2014 2015 2016 2017 2018 2019 2020
GCC Countries xx xx xx xx xx xx Xx
Egypt xx xx xx xx xx xx Xx
South Africa xx xx xx xx xx xx Xx
Nigeria xx xx xx xx xx xx Xx
Turkey xx xx xx xx xx xx Xx
Rest of MEA xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
10.2 Middle East and Africa Meningococcal Conjugate Vaccine
Market Size (2014-2020)
FIG. 33 Middle East and Africa Meningococcal Conjugate Vaccine
Market Share (%) by Country (2014-2020)

61. 61
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

62. 62
Global Meningococcal Conjugate Vaccine Market
2020
10.2.1 Middle East and Africa Meningococcal Conjugate
Vaccine Market (USD Million) Size by Type (2014-
2020)
TABLE 22 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD
Million) Size by Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Menactra xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 34 Middle East and Africa Meningococcal Conjugate Vaccine
Market Size by Type 2017
Source: Secondary Research, Interviews, and Expert Analysis

63. 63
Global Meningococcal Conjugate Vaccine Market
2020
10.2.2 Middle East and Africa Meningococcal Conjugate
Vaccine Market (USD Million) Size by Application
(2014-2020)
TABLE 23 Middle East and Africa Meningococcal Conjugate Vaccine Market (USD
Million) Size by Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Children xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
FIG. 35 Middle East and Africa Meningococcal Conjugate Vaccine
Market Size by Application 2017
Source: Secondary Research, Interviews, and Expert Analysis

64. 64
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 11 Global Meningococcal Conjugate Vaccine Market
Revenue (Value) by Type
11.1 Global Meningococcal Conjugate Vaccine Revenue and
Market Share (%) by Type (2014-2020)
TABLE 24 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by
Type (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Menactra xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
TABLE 25 Global Meningococcal Conjugate Vaccine Revenue Share (%) by Type
(2014-2020)
2014 2015 2016 2017 2018 2019 2020
Menactra xx xx xx xx xx Xx Xx
MENVEO xx xx xx xx xx Xx Xx
Total xx xx xx xx xx xx xx

65. 65
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 36 Global Meningococcal Conjugate Vaccine Market Revenue
Share (%) by Type (2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

66. 66
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 37 2018 Revenue Market Share (%) of Meningococcal Conjugate
Vaccine by Type
Source: Secondary Research, Interviews, and Expert Analysis

67. 67
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 12 Global Meningococcal Conjugate Vaccine Market
Revenue (Value) by Application
12.1 Global Meningococcal Conjugate Vaccine Revenue and
Market Share (%) by Application (2014-2020)
TABLE 26 Global Meningococcal Conjugate Vaccine Revenue (USD Million) by
Application (2014-2020)
2014 2015 2016 2017 2018 2019 2020
Children xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx
TABLE 27 Global Meningococcal Conjugate Vaccine Revenue Share (%) by Type
(2014-2020)
2014 2015 2016 2017 2018 2019 2020
Children xx xx xx xx xx Xx Xx
Adults xx xx xx xx xx Xx Xx
Total xx xx xx xx xx xx xx

68. 68
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 38 Global Meningococcal Conjugate Vaccine Market Revenue
Share (%) by Application (2014-2020)
Source: Secondary Research, Interviews, and Expert Analysis

69. 69
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 39 2018 Revenue Market Share (%) of Meningococcal Conjugate
Vaccine by Application
Source: Secondary Research, Interviews, and Expert Analysis

70. 70
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 13 Global Meningococcal Conjugate Vaccine
Manufacturers Profiles/Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Basic Information, Manufacturing Base,
Sales Area and its Competitors
TABLE 28 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and
Its Competitors
# Item Description
1 Company Name GlaxoSmithKline
2 Website xx
Established Date xx
4 Headquartered xx
6 Market Position or History xx
8 Contact Information xx

71. 71
Global Meningococcal Conjugate Vaccine Market
2020
13.1.2 Meningococcal Conjugate Vaccine Types Specification
Type Type Picture
xx xx
xx xx
xx xx
xx xx
xx xx
TABLE 29 GlaxoSmithKline Revenue (USD Million), Gross Margin (%) and Market
Share (%) (2014-2018)
Value 2014 2015 2016 2017 2018
Revenue xx xx xx xx xx
Gross Margin xx xx xx xx xx

72. 72
Global Meningococcal Conjugate Vaccine Market
2020
FIG. 40 GlaxoSmithKline Revenue Market Share (%) (2014-2018)
Source: Secondary Research, Interviews, and Expert Analysis
13.1.3 Main Business/Business Overview
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.
13.2 Pfizer
13.3 Sanofi
Kindly note company revenue will be subject to data available

73. 73
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 14 Meningococcal Conjugate Vaccine Manufacturing
Cost Analysis
14.1 Proportion of Manufacturing Cost Structure
FIG. 41 Manufacturing Cost Structure of Meningococcal Conjugate
Vaccine
Source: Secondary Research, Interviews, and Expert Analysis
14.1.1 Raw Materials
xxxxxxxxxxxxxxxxxxxxxxxxxxxxx.
14.1.2 Labor Cost
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx.
14.1.3 USA Labor Cost Analysis
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

74. 74
Global Meningococcal Conjugate Vaccine Market
2020
14.1.4 EU Labor Costs Analysis
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX.
14.1.5 China Labor Costs Analysis
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
14.1.6 Manufacturing Expenses
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

75. 75
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 15 Market Effect Factors Analysis
15.1 Consumer Needs/Customer Preference Change
XXXXXXXXXXXXXXXXXXXXX.
15.2 Economic/Political Environmental Change
FIG. 42 Economic/Political Environmental Change
Source: Secondary Research, Interviews, and Expert Analysis
U.S.
Shifting direction of policy
Europe
Economic activity in Western Europe will remain subdued
Africa
Growth to recover
moderately amid
challenges
East Asia
Domestic demand
continues to drive positive
near-term outlook amid
weak export performance
Japan
Policy easing supports
short-term prospects
Latin America and the
Caribbean
Return to positive growth in
2017, but strong external and
internal headwinds persist

76. 76
Global Meningococcal Conjugate Vaccine Market
2020
U.S.
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Europe
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Japan
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Africa
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
East Asia
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
Latin America and the Caribbean
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

77. 77
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 16 Global Meningococcal Conjugate Vaccine Market
Forecast (2020-2027)
16.1 Global Meningococcal Conjugate Vaccine Revenue Forecast
(2020-2027)
16.1.1 Global Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (%) Forecast (2020-2027)
FIG. 43 Global Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
xx
xx
xx
xx
xx
xx
xx
xx
xx
2020 2021 2022 2023 2024 2025 2026 2027
GrowthRate%
Revenue(USDMillion)
Revenue Growth Rate

78. 78
Global Meningococcal Conjugate Vaccine Market
2020
16.2 Global Meningococcal Conjugate Vaccine Revenue (USD
Million) Forecast by Regions (2020-2027)
TABLE 30 Global Meningococcal Conjugate Vaccine Revenue (USD Million)
Forecast by Regions (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
North America XX XX XX XX XX XX XX XX
Europe XX XX XX XX XX XX XX XX
Asia Pacific XX XX XX XX XX XX XX XX
Latin America XX XX XX XX XX XX XX XX
Middle East and Africa XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
FIG. 44 Global Meningococcal Conjugate Vaccine Revenue (USD
Million) Market Share (%) Forecast by Regions (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis

79. 79
Global Meningococcal Conjugate Vaccine Market
2020
16.2.1 North America Meningococcal Conjugate Vaccine
Revenue (USD Million) Forecast (2020-2027)
FIG. 45 North America Meningococcal Conjugate Vaccine Revenue
(USD Million) and Growth Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
16.2.2 Europe Meningococcal Conjugate Vaccine Revenue
(USD Million) Forecast (2020-2027)
FIG. 46 Europe Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (%) Forecast (2020-2027)

80. 80
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
16.2.3 Asia Pacific Meningococcal Conjugate Vaccine Revenue
(USD Million) Forecast (2020-2027)
FIG. 47 Asia Pacific Meningococcal Conjugate Vaccine Revenue (USD
Million) and Growth Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis

81. 81
Global Meningococcal Conjugate Vaccine Market
2020
16.2.4 Latin America Meningococcal Conjugate Vaccine
Revenue (USD Million) Forecast (2020-2027)
FIG. 48 Latin America Meningococcal Conjugate Vaccine Revenue
(USD Million) and Growth Rate (%) Forecast (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
16.2.5 Middle East and Africa Meningococcal Conjugate
Vaccine Revenue (USD Million) Forecast (2020-2027)
FIG. 49 Middle East and Africa Meningococcal Conjugate Vaccine
Revenue (USD Million) and Growth Rate (%) Forecast (2020-
2027)

82. 82
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

83. 83
Global Meningococcal Conjugate Vaccine Market
2020
16.3 Global Meningococcal Conjugate Vaccine Revenue and
Forecast by Type (2020-2027)
TABLE 31 Global Meningococcal Conjugate Vaccine Revenue (USD Million)
Forecast by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Menactra XX XX XX XX XX XX XX XX
MENVEO XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
FIG. 50 Global Meningococcal Conjugate Vaccine Revenue Market
Share (%) Forecast by Type (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis
16.4 Global Meningococcal Conjugate Vaccine Revenue and
Forecast by Application (2020-2027)
TABLE 32 Global Meningococcal Conjugate Vaccine Revenue (USD Million)
Forecast by Application (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Children XX XX XX XX XX XX XX XX
Adults XX XX XX XX XX XX XX XX

84. 84
Global Meningococcal Conjugate Vaccine Market
2020
Total XX XX XX XX XX XX XX XX
FIG. 51 Global Meningococcal Conjugate Vaccine Revenue Market
Share (%) Forecast by Application (2020-2027)
Source: Secondary Research, Interviews, and Expert Analysis

85. 85
Global Meningococcal Conjugate Vaccine Market
2020

86. 86
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 17 North America Meningococcal Conjugate Vaccine
Market Forecast 2020-2027
17.1 North America
17.1.1 North America Meningococcal Conjugate Vaccine
Market by Country, 2020-2027
TABLE 33 North America Meningococcal Conjugate Vaccine Market by Country
Revenue, 2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
U.S. XX XX XX XX XX XX XX XX
Canada XX XX XX XX XX XX XX XX
Mexico XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
17.1.2 North America Meningococcal Conjugate Vaccine
Market Size (2020-2027)
FIG. 52 North America Meningococcal Conjugate Vaccine Market Share
(%) by Country (2020-2027)

87. 87
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
17.1.3 North America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Type (2020-2027)
TABLE 34 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Menactra xx xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
17.1.4 North America Meningococcal Conjugate Vaccine
Revenue Market Size by Type 2022
FIG. 53 North America Meningococcal Conjugate Vaccine Revenue
Market Size by Type 2022

88. 88
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
17.1.5 North America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Application (2020-2027)
TABLE 35 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Children xx xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
17.1.6 North America Meningococcal Conjugate Vaccine
Revenue Market Size by Application 2022
FIG. 54 North America Meningococcal Conjugate Vaccine Revenue
Market Size by Application 2022

89. 89
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

90. 90
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 18 Europe Meningococcal Conjugate Vaccine Market
Forecast 2020-2027
18.1 Europe
18.1.1 Europe Meningococcal Conjugate Vaccine Market by
Country, 2020-2027
TABLE 36 Europe Meningococcal Conjugate Vaccine Market by Country Revenue,
2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
UK XX XX XX XX XX XX XX XX
France XX XX XX XX XX XX XX XX
Germany XX XX XX XX XX XX XX XX
Italy XX XX XX XX XX XX XX XX
Russia XX XX XX XX XX XX XX XX
Spain XX XX XX XX XX XX XX XX
Rest of Europe XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
18.1.2 Europe Meningococcal Conjugate Vaccine Market Size
(2020-2027)
FIG. 55 Europe Meningococcal Conjugate Vaccine Market Share (%)
by Country (2020-2027)

91. 91
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
18.1.3 Europe Meningococcal Conjugate Vaccine Market (USD
Million) Size by Type (2020-2027)
TABLE 37 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Menactra xx xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
18.1.4 Europe Meningococcal Conjugate Vaccine Revenue
Market Size by Type 2022
FIG. 56 Europe Meningococcal Conjugate Vaccine Revenue Market Size
by Type 2022

92. 92
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
18.1.5 Europe Meningococcal Conjugate Vaccine Market (USD
Million) Size by Application (2020-2027)
TABLE 38 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Children xx xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
18.1.6 Europe Meningococcal Conjugate Vaccine Revenue
Market Size by Application 2022
FIG. 57 Europe Meningococcal Conjugate Vaccine Revenue Market Size
by Application 2022

93. 93
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

94. 94
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 19 Asia Pacific Meningococcal Conjugate Vaccine
Market Forecast 2020-2027
19.1 Asia Pacific
19.1.1 Asia Pacific Meningococcal Conjugate Vaccine Market
by Country, 2020-2027
TABLE 39 Asia Pacific Meningococcal Conjugate Vaccine Market by Country
Revenue, 2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
China XX XX XX XX XX XX XX XX
Japan XX XX XX XX XX XX XX XX
India XX XX XX XX XX XX XX XX
Korea XX XX XX XX XX XX XX XX
South East Asia XX XX XX XX XX XX XX XX
Rest of APAC XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
19.1.2 Asia Pacific Meningococcal Conjugate Vaccine Market
Size (2020-2027)
FIG. 58 Asia Pacific Meningococcal Conjugate Vaccine Market Share
(%) by Country (2020-2027)

95. 95
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
19.1.3 Asia Pacific Meningococcal Conjugate Vaccine Market
(USD Million) Size by Type (2020-2027)
TABLE 40 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Menactra xx xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
19.1.4 Asia Pacific Meningococcal Conjugate Vaccine Revenue
Market Size by Type 2022
FIG. 59 Asia Pacific Meningococcal Conjugate Vaccine Revenue Market
Size by Type 2022

96. 96
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
19.1.5 Asia Pacific Meningococcal Conjugate Vaccine Market
(USD Million) Size by Application (2020-2027)
TABLE 41 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Children xx xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
19.1.6 Asia Pacific Meningococcal Conjugate Vaccine Revenue
Market Size by Application 2022
FIG. 60 Asia Pacific Meningococcal Conjugate Vaccine Revenue Market
Size by Application 2022

97. 97
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

98. 98
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 20 Latin America Meningococcal Conjugate Vaccine
Market Forecast 2020-2027
20.1 Latin America
20.1.1 Latin America Meningococcal Conjugate Vaccine
Market by Country, 2020-2027
TABLE 42 Latin America Meningococcal Conjugate Vaccine Market by Country
Revenue, 2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
Brazil XX XX XX XX XX XX XX XX
Argentina XX XX XX XX XX XX XX XX
Columbia XX XX XX XX XX XX XX XX
Rest of Latin America XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
20.1.2 Latin America Meningococcal Conjugate Vaccine
Market Size (2020-2027)
FIG. 61 Latin America Meningococcal Conjugate Vaccine Market Share
(%) by Country (2020-2027)

99. 99
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
20.1.3 Latin America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Type (2020-2027)
TABLE 43 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Menactra xx xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
20.1.4 Latin America Meningococcal Conjugate Vaccine
Revenue Market Size by Type 2022
FIG. 62 Latin America Meningococcal Conjugate Vaccine Revenue
Market Size by Type 2022

100. 100
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
20.1.5 Latin America Meningococcal Conjugate Vaccine
Market (USD Million) Size by Application (2020-2027)
TABLE 44 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Children xx xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
20.1.6 Latin America Meningococcal Conjugate Vaccine
Revenue Market Size by Application 2022
FIG. 63 Latin America Meningococcal Conjugate Vaccine Revenue
Market Size by Application 2022

101. 101
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

102. 102
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 21 Middle East and Africa Meningococcal Conjugate
Vaccine Market Forecast 2020-2027
21.1 Middle East and Africa
21.1.1 Middle East and Africa Meningococcal Conjugate
Vaccine Market by Country, 2020-2027
TABLE 45 Middle East and Africa Meningococcal Conjugate Vaccine Market by
Country Revenue, 2020-2027
2020 2021 2022 2023 2024 2025 2026 2027
GCC Countries XX XX XX XX XX XX XX XX
Egypt XX XX XX XX XX XX XX XX
South Africa XX XX XX XX XX XX XX XX
Nigeria XX XX XX XX XX XX XX XX
Turkey XX XX XX XX XX XX XX XX
Rest of MEA XX XX XX XX XX XX XX XX
Total XX XX XX XX XX XX XX XX
21.1.2 Middle East and Africa Meningococcal Conjugate
Vaccine Market Size (2020-2027)
FIG. 64 Middle East and Africa Meningococcal Conjugate Vaccine
Market Share (%) by Country (2020-2027)

103. 103
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
21.1.3 Middle East and Africa Meningococcal Conjugate
Vaccine Market (USD Million) Size by Type (2020-
2027)
TABLE 46 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Menactra xx xx xx xx xx xx xx Xx
MENVEO xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
21.1.4 Middle East and Africa Meningococcal Conjugate
Vaccine Revenue Market Size by Type 2022
FIG. 65 Middle East and Africa Meningococcal Conjugate Vaccine
Revenue Market Size by Type 2022

104. 104
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis
21.1.5 Middle East and Africa Meningococcal Conjugate
Vaccine Market (USD Million) Size by Application
(2020-2027)
TABLE 47 North America Meningococcal Conjugate Vaccine Market (USD Million)
Size by Type (2020-2027)
2020 2021 2022 2023 2024 2025 2026 2027
Children xx xx xx xx xx xx xx Xx
Adults xx xx xx xx xx xx xx Xx
Total xx xx xx xx xx xx xx xx
21.1.6 Middle East and Africa Meningococcal Conjugate
Vaccine Revenue Market Size by Application 2022
FIG. 66 Middle East and Africa Meningococcal Conjugate Vaccine
Revenue Market Size by Application 2022

105. 105
Global Meningococcal Conjugate Vaccine Market
2020
Source: Secondary Research, Interviews, and Expert Analysis

106. 106
Global Meningococcal Conjugate Vaccine Market
2020
Chapter 22 Research Findings and Conclusion
The global Meningococcal Conjugate Vaccine market was valued at USD XX Million
in year 2014 and is expected to reach USD XX Million by 2025.
On the basis of product type the market can be Segmented into Type 1, and Type
2. The Type 1 Segment accounted for major share in the market in 2017.
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

107. 107
Global Meningococcal Conjugate Vaccine Market
2020